Protagonist Therapeutics stockholder meeting approves director elections, say-on-pay, and auditor ratification

Protagonist Therapeutics, Inc

Harold Selick and Bryan Giraudo elected Class III directors with 27.9M and 28.1M votes for, respectively.
Advisory say-on-pay approved: 35.8M for, 0.4M against; 2.4M broker non-votes.
Non-binding vote favored annual say-on-pay frequency (35.6M for 1 year); company intends annual votes.
Ernst & Young ratified as auditor for FY2022: 38.7M for, 5.6K against, 1.5K abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.